Published in Nat Med on July 01, 1996
In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci U S A (2002) 3.28
Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol (2009) 2.89
Molecular characterization of lymphatic endothelial cells. Proc Natl Acad Sci U S A (2002) 2.68
Precocious mammary gland development in P-cadherin-deficient mice. J Cell Biol (1997) 2.10
Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Natl Acad Sci U S A (1997) 1.96
T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. Cancer Res (2008) 1.54
Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol (2000) 1.53
A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. Diabetes (2011) 1.33
CDO: an oncogene-, serum-, and anchorage-regulated member of the Ig/fibronectin type III repeat family. J Cell Biol (1997) 1.32
The tumor-suppressor function of E-cadherin. Am J Hum Genet (1998) 1.25
Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation. Br J Cancer (2003) 1.23
T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression. Mol Cell Biol (2003) 1.15
Differentiation and cancer in the mammary gland: shedding light on an old dichotomy. Adv Cancer Res (1998) 1.13
Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med Mol Morphol (2007) 1.12
The role and function of cadherins in the mammary gland. Breast Cancer Res (2012) 1.03
Promoter hypermethylation in prostate cancer. Cancer Control (2010) 0.99
Identification of T-cadherin as a novel target of DNA methyltransferase 3B and its role in the suppression of nerve growth factor-mediated neurite outgrowth in PC12 cells. J Biol Chem (2006) 0.99
Effect of DNA methylation on identification of aggressive prostate cancer. Urology (2008) 0.98
High incidence of MGMT and RARbeta promoter methylation in primary glioblastomas: association with histopathological characteristics, inflammatory mediators and clinical outcome. Mol Med (2009) 0.98
Aberrant DNA methylation and prostate cancer. Curr Genomics (2011) 0.98
Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Int J Clin Exp Pathol (2012) 0.92
A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females. BMC Cancer (2005) 0.91
DNA methylation in promoter region as biomarkers in prostate cancer. Methods Mol Biol (2012) 0.88
Suppression subtractive hybridization identifies distinctive expression markers for coronary and internal mammary arteries. Arterioscler Thromb Vasc Biol (2003) 0.87
Global gene expression analysis in time series following N-acetyl L-cysteine induced epithelial differentiation of human normal and cancer cells in vitro. BMC Cancer (2005) 0.85
Identification of genes involved in ceramide-dependent neuronal apoptosis using cDNA arrays. Genome Biol (2002) 0.85
Clinicopathological significance and potential drug target of T-cadherin in NSCLC. Drug Des Devel Ther (2014) 0.85
Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line. Mol Cancer (2008) 0.84
Chromosome band 16q24 is frequently deleted in human gastric cancer. Br J Cancer (1999) 0.84
Role of adiponectin and its receptors in cancer. Cancer Biol Med (2012) 0.83
The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females. BMC Cancer (2014) 0.83
Ordered subset analysis identifies loci influencing lung cancer risk on chromosomes 6q and 12q. Cancer Epidemiol Biomarkers Prev (2010) 0.82
Expression of cathepsin D and E-cadherin in primary laryngeal cancers correlation with neck lymph node involvement. J Cancer Res Clin Oncol (2011) 0.81
T-/H-cadherin (CDH13): a new marker for differentiating podocytes. Virchows Arch (2005) 0.80
An adiponectin receptor, T-cadherin, was selectively expressed in intratumoral capillary endothelial cells in hepatocellular carcinoma: possible cross talk between T-cadherin and FGF-2 pathways. Virchows Arch (2005) 0.79
Association study of ARL15 and CDH13 with T2DM in a Han Chinese population. Int J Med Sci (2014) 0.79
Effects of T-cadherin expression on B16F10 melanoma cells. Oncol Lett (2013) 0.77
A soluble truncated cadherin induces breast cancer cell apoptosis and growth inhibition. J Cancer Res Clin Oncol (2006) 0.77
Gene-gene interaction analysis identifies a new genetic risk factor for colorectal cancer. J Biomed Sci (2015) 0.77
HPV16 integration probably contributes to cervical oncogenesis through interrupting tumor suppressor genes and inducing chromosome instability. J Exp Clin Cancer Res (2016) 0.75
Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis. BMC Urol (2016) 0.75
Role of CDH13 promoter methylation in the carcinogenesis, progression, and prognosis of colorectal cancer: A systematic meta-analysis under PRISMA guidelines. Medicine (Baltimore) (2017) 0.75
DC-CLM, a cadherin-like molecule cloned from human dendritic cells, inhibits growth of breast cancer cells. J Cancer Res Clin Oncol (2003) 0.75
T-cadherin is associated with prognosis in triple-negative breast cancer. Oncol Lett (2017) 0.75